AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Recticel

Quarterly Report Feb 26, 2021

3993_er_2021-02-26_bec2aab2-21cc-47ad-8285-97e9f2a49c8e.pdf

Quarterly Report

Open in Viewer

Opens in native device viewer

PRESS RELEASE

Regulated information – Inside information

Brussels, 26 February 2021 – 07:00 CET

Recticel Annual Results2020

Solid 2nd half 2020 and Strategic Repositioning

  • Net sales: from EUR 878.5 million1 to EUR 828.8million (-5.7%), including a -0.3% currency effect
  • Adjusted EBITDA: from EUR 70.7 million1 to EUR 58.8 million (-16.8%)
  • Result of the period (share of the Group): from EUR 24.8 million to EUR 63.2 million, including EUR 68.7 million result from discontinued operations
  • Net financial debt (cash): EUR 4.6 million, including IFRS 16 lease liabilities
  • Proposal to pay a gross dividend of EUR 0.26 per share

Olivier Chapelle (CEO): "After a -17.5% sales decline in 1H2020 caused by the COVID-19 lockdown, the 2H2020 was marked by significant sales fluctuations varying from one business segment or country to another, influenced by the subsequent waves of the COVID pandemic and the related precautionary measures taken by national governments. In this difficult context, we managed to generate a robust 7.0% sales growth in 2H2020 and a 10.0% increase in Adjusted EBITDA.

Numerous 'force majeure' events at the premises of our chemical raw material suppliers have created and continue to create supply shortages of polyols and isocyanates. Our suppliers have used this situation to implement price increases at an historically high pace, leading to new all-time highs. In response to this, we were compelled to mitigate these cost increases through corresponding sale price increases. The situation is expected to normalize as of 3Q2021.

2020 has also been a milestone year for the important strategic repositioning of our Group. We have at last succeeded in divesting our Automotive Interiors operations, which, together with the disposal of our 50% participation in the Eurofoam joint venture, has enabled the signing of the acquisition of FoamPartner. This transaction will create a truly global playerin Engineered Foams, and the preparation of its closing is progressing well.

While pursuing further external growth opportunities, the Board of Directors has now also decided to launch a divestment process for our Bedding division, in line with our amended strategy."

OUTLOOK

1

Our underlying end-use markets remain difficult to predict in the context of the COVID-19 pandemic. Regardless of these uncertainties, ourGroupexpects in 2021 a substantial increase insales, and a 30% increase of its Adjusted EBITDA, not taking into account the contribution from the FoamPartner acquisition nor the related synergies.

To facilitate comparisons and understanding of the Group's underlying performance, all comments in this document on developments in revenue or results are made on a like-for-like basis unless otherwise indicated.

Following the partial divestment from Automotive Interiors on 30 June 2020 (see press release of 01 July 2020), Automotive Interiors is integrated in the consolidated accounts according to the 'equity method'. Following the loss of control as a result of the partial divestment of Automotive Interiors and the sale of Eurofoam, the 2019 consolidated income statement was restated to present these as discontinued operations.

1. CONSOLIDATED GROUP RESULTS

in million EUR 2H2019 2H2019 2H2020 D % FY2019 FY2019 FY2020 D %
Sales as published
502.4
restated 1
424.7
454.5 7.0% as published
1 038.5
restated 1
878.5
828.8 -5.7%
Gross profit 89.9 80.7 91.7 13.6% 191.1 168.7 157.0 -6.9%
as % of sales 17.9% 19.0% 20.2% 18.4% 19.2% 18.9%
Income from associates 3 4.5 0.6 0.3 -53.8% 9.3 1.3 0.7 -45.7%
Adjusted EBITDA n.a. 36.1 39.8 10.0% n.a. 70.7 58.8 -16.8%
as % of sales 8.5% 8.7% 8.1% 7.1%
EBITDA 42.0 30.3 34.2 12.9% 95.3 60.7 51.6 -15.0%
as % of sales 8.4% 7.1% 7.5% 9.2% 6.9% 6.2%
Adjusted operating profit (loss) n.a. 18.0 22.6 25.5% n.a. 34.8 23.5 -32.5%
as % of sales 4.2% 5.0% 4.0% 2.8%
Operating profit (loss) 12.4 12.1 16.7 37.9% 37.1 24.4 13.8 -43.3%
as % of sales 2.5% 2.9% 3.7% 3.6% 2.8% 1.7%
Financial result ( 3.6) ( 1.4) ( 2.6) 79.1% ( 8.2) ( 4.2) ( 5.1) 21.9%
Income from other associates 3 - ( 1.6) ( 2.8) n.m. - 1.0 ( 5.8) n.m.
Impairment other associates - 0.0 ( 5.5) n.m. - 0.0 ( 5.5) n.m.
Change in fair value of option structures - 0.9 ( 0.6) n.m. - 3.8 1.1 n.m.
Income taxes ( 0.2) 1.7 ( 2.0) -213.3% ( 4.2) ( 0.9) ( 4.0) 354.3%
Result of the period of the continuing operations 8.6 11.7 3.2 -72.7% 24.7 24.0 ( 5.5) -123.0%
Result of the discontinued operations 0.0 ( 3.1) ( 0.1) n.m. 0.0 0.7 68.7 n.m.
Result of the period (share of the Group) 8.7 8.7 3.0 -64.9% 24.8 24.8 63.2 155.0%
Result of the period (share of the Group)
- base (per share, in EUR)
0.16 0.16 0.04 -73.3% 0.45 0.45 1.13 153.5%
31 Dec 2019 31 Dec 2019 31 Dec 2020 31 Dec 2019 31 Dec 2019 31 Dec 2020
Total Equity 275.4 275.4 334.8 21.6% 275.4 275.4 334.8 21.6%
Net Financial Debt (incl. IFRS 16 - Leases) 2
168.6
2
96.7
4.6 -95.2% 2
2
168.6
2
96.7
4.6 -95.2%
Gearing ratio (Net financial debt/Total Equity) 61.2% 35.1% 1.4% 61.2% 35.1% 1.4%
Leverage ratio (Net financial debt/EBITDA) 2.0 1.6 0.1 1.8 1.6 0.1

2 Excluding the draw n amounts under non-recourse factoring programs: EUR 0.0 million per 31 December 2020 versus EUR 47.0 million per 31 December 2019 and EUR 0.0 million per 30 June 2020

3 Income from associates = income from associates considered as being part of the Group's core business are integrated in Operating profit (loss); i.e. Orsafoam Income from other associates = income from associates not considered as being part of the Group's core business are not integrated in Operating profit (loss); i.e. Proseat and Automotive Interiors

The following changes in the scope of consolidation took place in 2020:

  • Disposal of the 50% participation in the Eurofoam group (Flexible Foams) on 30 June 2020.
  • Partial divestment of the Automotive Interiors activities on 30 June 2020, now operated through a new 51/49% Admetos/Recticel joint venture.

Consequently, the 1H2020 net result of the Automotive Interiors activities and Eurofoam are reported under discontinued operations and the 2H2020 net result of Automotive Interiors is included under 'Income from other associates'.

The Automotive segment is no longer reported separately.

Sales of chemical raw materials at cost to the Proseat and Automotive Interiors companies, which were reported under the segment Automotive until 2019, are now integrated under "Corporate/Eliminations".

Net Sales: on a like-for-like basis1 sales decreased by 5.7% from EUR 878.5 million1 to EUR 828.8 million, including a currency impact of -0.3%.

Sales recovered strongly in the second half-year (+7.0% y/y), after a first half-year severely impacted by the first wave of the COVID-19 pandemic (-17.5% y/y). Despite the development of a second COVID-19 wave since the autumn, sales increased over the third (+2.5%) and fourth quarter (+11.5%), supported by recovering volumes and higher selling prices, compensating for the steep increase in chemical raw material costs induced by many force majeure events at our main suppliers.

majeure
events at our main suppliers.
Breakdown of the sales by segment
FY2019
D
in million EUR
1Q2020
2Q2020
3Q2020
4Q2020
FY2020
FY
restated 1
Flexible Foams 361.1 89.4 57.7 81.5 93.3 322.0 -10.8%
Bedding 242.3 65.2 44.0 68.3 64.3 241.8 -0.2%
Insulation 247.2 60.7 52.0 65.0 71.5 249.2 0.8%
Corporate / Eliminations 28.0 6.2 ( 1.0) 2.6 8.0 15.8 -43.5%
TOTAL CONSOLIDATED SALES
878.5
221.5
152.8
217.4
237.2
828.8
-5.7%

Breakdown of the sales by segment

in million EUR restated 1 restated 1 2020 versus 2019 restated
1Q2019 2Q2019 1H2019 1Q2020 2Q2020 1H2020 D 1Q D 2Q D 1H
Flexible Foams 96.8 92.6 189.4 89.4 57.7 147.1 -7.7% -37.7% -22.3%
Bedding 64.3 55.6 119.8 65.2 44.0 109.2 1.4% -20.7% -8.9%
Insulation 62.5 67.4 129.8 60.7 52.0 112.7 -2.9% -22.8% -13.2%
Corporate / Eliminations 4.6 10.1 14.7 6.2 ( 1.0) 5.2 33.3% -110.2% -64.9%
TOTAL CONSOLIDATED SALES 228.3 225.6 453.8 221.5 152.8 374.3 -3.0% -32.3% -17.5%
in million EUR restated 1 restated 1 2020 versus 2019 restated
3Q2019 4Q2019 2H2019 3Q2020 4Q2020 2H2020 D 3Q D 4Q D 2H
Flexible Foams 84.3 87.4 171.7 81.5 93.3 174.8 -3.3% 6.8% 1.8%
Bedding 57.8 64.6 122.4 68.3 64.3 132.5 18.1% -0.6% 8.2%
Insulation 62.9 54.4 117.3 65.0 71.5 136.5 3.3% 31.5% 16.4%
Corporate / Eliminations 7.0 6.3 13.3 2.6 8.0 10.7 -62.6% 28.0% -19.8%
TOTAL CONSOLIDATED SALES 212.0 212.7 424.7 217.4 237.2 454.5 2.5% 11.5% 7.0%
in million EUR restated 1 restated 1 2020 versus 2019 restated
1H2019 2H2019 FY2019 1H2020 2H2020 FY2020 D 1H D 2H D FY
Flexible Foams 189.4 171.7 361.1 147.1 174.8 322.0 -22.3% 1.8% -10.8%
Bedding 119.8 122.4 242.3 109.2 132.5 241.8 -8.9% 8.2% -0.2%
Insulation 129.8 117.3 247.2 112.7 136.5 249.2 -13.2% 16.4% 0.8%
Corporate / Eliminations 14.7 13.3 28.0 5.2 10.7 15.8 -64.9% -19.8% -43.5%
TOTAL CONSOLIDATED SALES 453.8 424.7 878.5 374.3 454.5 828.8 -17.5% 7.0% -5.7%

All segments reported higher sales during 2H2020:

  • Flexible Foams sales increased by 1.8% over 2H2020. Volumes remained subdued due to a combination of softer demand linked to 2H2020 COVID-19 restrictions and to limited availability of chemical raw materials. Increased chemical raw materials costs were passed on to the market as from September 2020, resulting in higher selling prices.
  • Bedding sales increased by 8.2% over 2H2020, thanks to very strong demand as soon as the restrictions imposed on retail shopping in most European countries between March and May 2020 were lifted.

Sales have grown significantly over 3Q2021 (+18.1%) on the back of a strong orderbook, but 4Q2020 was stable (-0.6% y/y), due to raw material supply constraints.

  • Insulation sales increased by 16.4% over 2H2020, with strong volumes throughout 2H2020 in combination with higher selling prices resulting from the increase in chemical raw material input costs.

Adjusted EBITDA: EUR 58.8 million versus EUR 70.7 million1 in 2019.

Adjusted EBITDA margin of 7.1% versus 8.1%1 in 2019.

Adjusted EBITDA margin of 7.1% versus 8.1%1 in 2019.
Breakdown of the Adjusted EBITDA by segment
in million EUR 1H2019
restated 1
2H2019
restated 1
FY2019
restated 1
1H2020 2H2020 FY2020 D
1H
D
2H
D FY
Flexible Foams 18.8 18.3 37.2 10.3 18.3 28.6 -45.4% -0.3% -23.1%
Bedding 6.9 9.9 16.9 4.5 13.7 18.2 -34.6% 37.7% 8.0%
Insulation 17.1 14.5 31.6 11.3 16.4 27.7 -33.9% 13.0% -12.3%
Corporate ( 8.2) ( 6.7) ( 14.9) ( 7.0) ( 8.6) ( 15.6) -14.4% 29.4% 5.2%
TOTAL
CONSOLIDATED
ADJUSTED EBITDA
34.6 36.1 70.7 19.1 39.8 58.8 -44.9% 10.0% -16.8%

Although COVID-19 particularly impacted Adjusted EBITDA in 1H2020 (-44.9% y/y), a solid recovery was observed in 2H2020, with an Adjusted EBITDA growth of +10.0% y/y.

After a first half during which the negative volume impact could be mitigated to a great extent by cost saving measures and the implementation of temporary unemployment, 2H2020 benefitted from recovering volumes in Insulation and Bedding and disciplined selling price adjustments to compensate for the higher chemical raw material costs.

Many force majeure events have occurred after the restart of the suppliers' production lines which had been stopped during the first lockdown -, and have resulted in an extremely tight supply situation over the last 4 months of the year. The shortage has been invoked by our suppliers to increase their prices at a historical speed, and to new record levels. The Group has implemented selling price increases accordingly to protect its profit margins.

Adjusted operating profit (loss): EUR 23.5 million versus EUR 34.8 million1 in 2019.

Adjusted operating profit (loss) margin of 2.8% versus 4.0%1 in 2019.

Breakdown of the Adjusted operating profit (loss) by segment

Adjusted operating profit (loss) margin of 2.8% versus 4.0%1 in 2019.
Breakdown of the Adjusted operating profit (loss) by segment
in million EUR 1H2019
restated 1
2H2019
restated 1
FY2019
restated 1
1H2020 2H2020 FY2020 D
1H
D
2H
D FY
Flexible Foams 12.0 11.1 23.1 3.1 11.2 14.4 -73.8% 1.4% -37.7%
Bedding 2.5 5.7 8.2 0.0 10.2 10.2 -99.4% 79.1% 25.5%
Insulation 11.5 9.4 20.9 5.9 11.2 17.1 -48.4% 19.1% -18.0%
Corporate ( 9.1) ( 8.2) ( 17.2) ( 8.2) ( 10.0) ( 18.2) -9.9% 22.8% 5.6%
TOTAL ADJUSTED
OPERATING PROFIT (LOSS)
16.8 18.0 34.8 0.9 22.6 23.5 -94.7% 25.5% -32.5%

Adjustments to Operating profit (loss):

in million EUR 1H2019
restated1
2H2019
restated1
FY2019
restated1
1H2020 2H2020 FY2020
Restructuring charges and provisions ( 1.1) ( 5.6) ( 6.7) ( 1.4) ( 0.6) ( 2.0)
Other ( 3.1) ( 0.3) ( 3.4) ( 0.3) ( 4.9) ( 5.2)
Total impact on EBITDA ( 4.2) ( 5.8) ( 10.0) ( 1.7) ( 5.5) ( 7.2)
Impairments ( 0.3) ( 0.1) ( 0.4) ( 2.1) ( 0.4) ( 2.4)
Total impact on Operating profit
(loss)
( 4.5) ( 5.9) ( 10.4) ( 3.8) ( 5.9) ( 9.7)

Adjustments to Operating profit (loss) in 2020 include mainly (i) reorganisation charges in Flexible Foams (EUR 0.9 million) and Bedding (EUR 1.0 million), (ii) due diligence and legal fees and expenses linked to the FoamPartner acquisition - cfr press release of 10 November 2020 - (EUR 4.9 million) and (iii) impairments on idle assets in Flexible Foams in Spain (EUR 1.3 million) and in Bedding following the closure of the Hassfurt plant (Germany) (EUR 1.1 million).

EBITDA: EUR 51.6 million versus EUR 60.7 million1 in 2019.

Breakdown of EBITDA by segment

EBITDA margin of 6.2% versus 6.9%1 in 2019.
Breakdown of EBITDA by segment
in million EUR 1H2019
restated 1
2H2019
restated 1
FY2019
restated 1
1H2020 2H2020 FY2020 D
1H
D
2H
D FY
Flexible Foams 19.3 14.9 34.1 9.5 17.9 27.4 -50.9% 20.1% -19.9%
Bedding 6.8 9.3 16.0 3.5 13.6 17.1 -47.6% 46.7% 7.0%
Insulation 17.1 14.4 31.4 11.2 16.3 27.5 -34.3% 13.4% -12.5%
Corporate ( 12.7) ( 8.2) ( 20.9) ( 6.8) ( 13.6) ( 20.4) -46.0% 64.9% -2.3%
TOTAL
CONSOLIDATED
EBITDA
30.4 30.3 60.7 17.4 34.2 51.6 -42.8% 12.9% -15.0%

Operating profit (loss): EUR 13.8 million versus EUR 24.4 million1 in 2019.

Operating profit (loss) margin of 1.7% versus 2.8%1 in 2019.

Breakdown of Operating profit (loss) by segment

Operating profit (loss) margin of 1.7% versus 2.8%1 in 2019.
Breakdown of Operating profit (loss) by segment
in million EUR 1H2019
restated 1
2H2019
restated 1
FY2019
restated 1
1H2020 2H2020 FY2020 D
1H
D
2H
D FY
Flexible Foams 12.4 7.6 20.0 1.2 10.7 11.9 -90.1% 40.8% -40.6%
Bedding 2.0 5.0 7.0 ( 1.9) 10.0 8.1 -194.7% 97.5% 15.1%
Insulation 11.4 9.3 20.7 5.8 11.1 16.9 -48.8% 19.9% -18.0%
Corporate ( 13.5) ( 9.7) ( 23.3) ( 8.1) ( 15.0) ( 23.1) -40.2% 54.2% -0.8%
TOTAL
OPERATING PROFIT (LOSS)
12.3 12.1 24.4 ( 2.9) 16.7 13.8 -123.5% 37.7% -43.4%

Financial result: from EUR -4.2 million1 to EUR -5.1 million:

Net interest charges: EUR -3.4 million – of which EUR -2.1 million relating to leases – versus EUR -2.8 million1 in 2019.

'Other net financial income and expenses': EUR -1.7 million versus EUR -1.4 million1 in 2019. This item comprises mainly interest capitalisation costs under provisions for pension liabilities (EUR -0.3 million versus EUR -0.8 million1 in 2019) and exchange rate differences (EUR -1.4 million versus EUR -0.6 million1 in 2019).

Income from other associates : EUR -5.7 million relates to the reported results in Proseat (EUR -5.1 million) and in Automotive Interiors (EUR -0.6 million).

Impairment other associates : EUR -5.5 million on the Proseat participation.

Fair value of option structures : EUR +1.1 million relates to an adjustment of the fair value of the put/call structure on the 25% Proseat participation. The put/call structure on the remaining 49% participation in the Automotive Interiors joint-venture has been maintained at a 'zero' value given the uncertainties over the period until the earliest exercise date of the options (2024).

Income and deferred taxes: from EUR -0.9 million1 to EUR -4.0 million:

  • Current income tax: EUR -4.0 million (2019: EUR -3.6 million1 );
  • Deferred tax: EUR -0.02 million (2019: EUR +2.7 million1 ).

Result of the period from continuing operations: EUR -5.5 million versus EUR +24.1 million1 in 2019.

Result from discontinued operations: EUR +68.7 million

The total result of discontinued operations consists of:

  • (i) the net gain related to the divestment of the 50% participation in the Eurofoam group,
  • (ii) the net loss realised on the sale of 49% of the Automotive Interiors activities, and
  • (iii) the pro rata share of the 1H2020 result of the period after taxes of Eurofoam (50%) and Automotive Interiors activities (100%).

Consolidated result of the period (share of the Group): EUR + 63.2 million versus EUR 24.7 million in 2019.

2. FINANCIAL POSITION

31 DEC 31 MAR 30 JUN 30 SEP 31 DEC
in million EUR 2019 2020 2020 2020 2020
TOTAL EQUITY 276.6 - 331.5 - 334.8
Net financial debt excluding factoring 88.6 121.4 ( 11.4) ( 43.7) ( 47.9)
+ Drawn amounts under factoring programs 47.1 32.1 0.0 0.0 0.0
+ Impact of application IFRS 16 80.0 77.6 55.2 52.9 52.5
TOTAL CONSOLIDATED NET FINANCIAL DEBT 215.6 231.1 43.8 9.3 4.6
Gearing ratio (incl. IFRS 16 ) 60.9% - 13.2% - 1.4%
Leverage ratio (incl. IFRS 16) 1.8 - 0.7 - 0.1

The Group's net cash position - excluding IFRS16 debt - increased by EUR 4.2 million over 4Q2020 to reach EUR 47.9 million.

On 4 December 2020 the Group entered into (i) a new EUR 100 million syndicated revolving credit facility to replace the EUR 175 million 'club deal' facility maturing in February 2021 and (ii) a EUR 205 million acquisition financing facility to finance the acquisition of FoamPartner (cfr press release of 10 November 2020), planned to be closed as soon as all anti-trust approvals will have been obtained.

Both facilities have been arranged and underwritten by KBC Bank. Belfius Bank, BNP Paribas Fortis, Commerzbank and LCL confirmed their participation. Both facilities have a 3-year tenor with two 1-year extension options.

3. MARKET SEGMENTS

3.1. FLEXIBLE FOAMS

3.1.
FLEXIBLE FOAMS
in million EUR 1H2019 2H2019 FY2019 1H2020 2H2020 FY2020 D
1H
D
2H
D
FY
restated1 restated1 restated1
Sales 189.4 171.7 361.1 147.1 174.8 322.0 -22.3% 1.8% -10.8%
Adjusted EBITDA 18.8 18.3 37.2 10.3 18.3 28.6 -45.4% -0.3% -23.1%
as % of sales 9.9% 10.7% 10.3% 7.0% 10.5% 8.9%
EBITDA 19.3 14.9 34.1 9.5 17.9 27.4 -50.9% 20.1% -19.9%
as % of sales 10.2% 8.7% 9.5% 6.4% 10.2% 8.5%
Adjusted operating profit (loss) 12.0 11.1 23.1 3.1 11.2 14.4 -73.8% 1.4% -37.7%
as % of sales 6.3% 6.5% 6.4% 2.1% 6.4% 4.5%
Operating profit (loss) 12.4 7.6 20.0 1.2 10.7 11.9 -90.1% 40.8% -40.6%
as % of sales 6.6% 4.4% 5.5% 0.8% 6.1% 3.7%

Sales

Fourth quarter 2020

Sales increased by 6.8% in 4Q2020 from EUR 87.4 million1 in 4Q2019 to EUR 93.3 million, including a -1.7% impact from exchange rate differences. External sales increased by 6.0% from EUR 79.9 million1 to EUR 84.7 million, including the impact of passing on higher chemical raw material costs to the market.

Full-year 2020

Although market demand restored as of September, COVID-induced sales reduction in 1H2020 (-22.3% on a like-for-like1 basis), could not be compensated during 2H2020 (+1.8%). Sales decreased from EUR 361.1 million1 to EUR 322.0 million (-10.8%), including a -0.9% impact from exchange rate differences. External sales decreased by 12.0% from EUR 332.0 million1 to EUR 292.2 million.

Selling prices were increased as of September 2020 to compensate for the steep surge in chemical raw material prices following several force majeure events and other supply issues in the upstream value chain.

Profitability

Although profitability gradually improved after Q2, the like-for-like1 Adjusted EBITDA margin decreased to 8.9% (2019: 10.3%1 ). The margin reduction is fully explained by the negative volume impact leading to unabsorbed fixed costs, partially mitigated by cost saving measures, including temporary unemployment and pricing efforts.

EBITDA includes adjustments for EUR -1.2 million (2019: EUR -3.0 million1 ): of which EUR - 0.9 million of restructuring charges in The Netherlands and Spain.

3.2. BEDDING

3.2.
BEDDING
in million EUR 1H2019 2H2019 FY2019 1H2020 2H2020 FY2020 D
1H
D
2H
D
FY
Sales 119.8 122.4 242.3 109.2 132.5 241.8 -8.9% 8.2% -0.2%
Adjusted EBITDA 6.9 9.9 16.9 4.5 13.7 18.2 -34.6% 37.7% 8.0%
as % of sales 5.8% 8.1% 7.0% 4.2% 10.3% 7.5%
EBITDA 6.8 9.3 16.0 3.5 13.6 17.1 -47.6% 46.7% 7.0%
as % of sales 5.6% 7.6% 6.6% 3.2% 10.3% 7.1%
Adjusted operating profit (loss) 2.5 5.7 8.2 0.0 10.2 10.2 -99.4% 79.1% 25.5%
as % of sales 2.0% 4.7% 3.4% 0.0% 7.7% 4.2%
Operating profit (loss) 2.0 5.0 7.0 ( 1.9) 10.0 8.1 -194.7% 97.5% 15.1%
as % of sales 1.7% 4.1% 2.9% -1.7% 7.5% 3.3%

Sales

Fourth quarter 2020

Sales slightly decreased from EUR 64.6 million in 4Q2019 to EUR 64.3 million in 4Q2020 (- 0.6%), including a +0.7% impact of exchange rate differences. External sales decreased by 0.1% to EUR 63.3 million in 4Q2020.

The strong momentum observed during 3Q2020 (+18.1%) - compensating for the volume shortfall in 2Q2020 (-20.7%) following the COVID-19 retail shopping restrictions imposed in most European countries – lost some of its momentum in 4Q2020 as new mobility restrictions (2nd COVID-19 wave) and raw material shortages dampened intrinsic volume growth.

Full-year 2020

Over 2020, sales remained stable despite the impact of COVID-19 on the retail sector. Sales amounted to EUR 241.8 million (-0.2%) versus EUR 242.3 million in 2019, including a +0.7% impact from exchange rate differences. External sales increased by 0.4% from EUR 237.3 million to EUR 238.2 million.

The sub-segment "Branded Products" (+3.8%) held firm given the challenging market environment, whereas the sub-segment "Non-Branded/Private Label" receded by 6.4%. Both sub-segments were heavily impacted during the second quarter by the COVID-19 retail shopping restrictions imposed in most European countries.

Profitability

The Adjusted EBITDA margin reached 7.5% versus 7.0% in 2019. The improved profitability was induced by positive mix effects and lower operating costs.

Despite the COVID-19 crisis, EBITDA increased from EUR 16.0 million to EUR 17.1 million; including non-recurring costs for EUR -1.1 million following the implementation of cost saving measures (2019: EUR -0.9 million).

3.3. INSULATION

3.3.
INSULATION
in million EUR 1H2019 2H2019 FY2019 1H2020 2H2020 FY2020 D
1H
D
2H
D
FY
Sales 129.8 117.3 247.2 112.7 136.5 249.2 -13.2% 16.4% 0.8%
Adjusted EBITDA 17.1 14.5 31.6 11.3 16.4 27.7 -33.9% 13.0% -12.3%
as % of sales 13.1% 12.4% 12.8% 10.0% 12.0% 11.1%
EBITDA 17.1 14.4 31.4 11.2 16.3 27.5 -34.3% 13.4% -12.5%
as % of sales 13.1% 12.3% 12.7% 9.9% 11.9% 11.0%
Adjusted operating profit (loss) 11.5 9.4 20.9 5.9 11.2 17.1 -48.4% 19.1% -18.0%
as % of sales 8.8% 8.0% 8.4% 5.2% 8.2% 6.9%
Operating profit (loss) 11.4 9.3 20.7 5.8 11.1 16.9 -48.8% 19.9% -18.0%
as % of sales 8.8% 7.9% 8.4% 5.2% 8.1% 6.8%

Sales

Fourth quarter 2020

Sales increased from EUR 54.4 million in 4Q2019 to EUR 71.5 million in 4Q2020 (+31.5%), including a -1.5% impact of exchange rate differences.

The sales increase results from strong volume development and selling price increases implemented to compensate for the steep surge in chemical raw material prices following a tighter supply in the upstream supply chain.

The new plant in Finland continues to increase its output.

In 4Q2020 demand for VIP (vacuum insulation panel) material has sharply increased, boosted by demand for ultra-high performance insulation materials needed for the transportation and storage of COVID-19 vaccines.

Full-year 2020

Despite the impact of COVID-19 – mainly in 2Q2020 –, sales slightly exceeded the level of 2019 thanks to solid demand leading to increased volumes: EUR249.2millionversusEUR 247.2 million to (+0.8%), including a currency impact of -0.5%.

EC stimulus plans and green regulatory incentives will remain a key volume driver in Europe in 2021.

Profitability

Adjusted EBITDA margin of 11.1% versus 12.8% in 2019.

The profitability decline in 2020 results from (i) lower profit in 1H2020 due to sub-critical asset utilisation linked to COVID-19 impacted volumes, and (ii) higher profit in 2H2020 due to strong volumes, but partially mitigated by steep raw material price increases.

The new Finnish plant ramp-up is progressing well taking into account the COVID-19 impact and is expected to lead to break-even in 2H2021.

4. STRATEGIC REVIEW BEDDING

The Board of Directors has completed the strategic review of the Bedding business segment and decided to divest the segment in order to focus on the core segments Insulation and Engineered Foams.

Recticel Bedding is a leading European manufacturer and distributor of branded and unbranded mattresses, slats, bed bases and finished beds. The business operates through a distinguished portfolio of brands including Geltex®, Schlaraffia®, Superba®, Swissflex®, Sembella®, Literie Bultex®, Beka® and Lattoflex® sold mainly in Belgium, Germany, the Netherlands, Poland, Austria and Switzerland. The divestment will provide an opportunity for the segment to unlock its full potential under the ownership of a dedicated shareholder.

The next few months will be used to prepare the carve-out. J.P. Morgan has been retained to advise Recticel on the divestment.

5. PROPOSED DIVIDEND

The Board of Directors will propose to the Annual General Meeting of 25 May 2021 the payment of a gross dividend of EUR 0.26 per share on 55.7 million shares or a total dividend pay-out of EUR 14.5 million (2019: respectively EUR 0.24/share and EUR 13.3 million in total).

APPENDICES

All figures and tables contained in these annexes have been compiled in accordance with the IFRS accounting and valuation principles, as adopted within the European Union. The applied valuation principles, as published in the latest annual report at 31 December 2019, were applied for the figures included in this press release.

The analysis of the risk management is described in the annual report and the IAS 34 Interim report per 30 June 2020, b oth which are available from www.recticel.com.

1. Condensed consolidated income statement

Group Recticel 2019 2020 D
in thousand EUR restated 1
(a) (b) (b)/(a)-1
Sales 878 521 828 792 -5.7%
Distribution costs ( 55 892) ( 54 849) -1.9%
Cost of sales ( 653 965) ( 616 913) -5.7%
Gross profit 168 664 157 030 -6.9%
General and administrative expenses ( 58 349) ( 57 949) -0.7%
Sales and marketing expenses ( 66 950) ( 60 624) -9.4%
Research and development expenses ( 10 643) ( 9 281) -12.8%
Impairments goodwill, tangible and intangible
assets
( 396) ( 2 440) 516.2%
Other operating revenues 8 384 15 514 85.0%
Other operating expenses ( 17 587) ( 29 103) 65.5%
Income from associates 1 294 703 -45.7%
Operating profit (loss) 24 417 13 850 -43.3%
Interest income 2 759 909 -67.1%
Interest expenses ( 5 541) ( 4 329) -21.9%
Other financial income 9 273 5 294 -42.9%
Other financial expenses ( 10 711) ( 7 018) -34.5%
Financial result ( 4 220) ( 5 144) 21.9%
Income from other associates 962 ( 5 790) -701.9%
Impairments other associates 0 ( 5 525) n.m.
Change in fair value of option structures 3 762 1 103 -70.7%
Result of the period before taxes 24 921 ( 1 506) -106.0%
Income taxes ( 886) ( 4 025) 354.3%
Result of the period after taxes - continuing
operations
24 035 ( 5 531) -123.0%
Result of the period after taxes - discontinued
operations
683 68 686 n.m.
Result of the period after taxes - continuing
and discontinued operations
24 718 63 155 155.5%
of which attributable to the owners of the parent 24 762 63 151 155.0%
of which attributable to non-controlling interests ( 44) 4 -109.1%

A distinction has been made betw een Income from associates - included in operating profit (loss) - and Income from other associates - excluded from operating profit (loss).

Income from associates: income from associates considered as being part of the Group's core business are integrated in Operating profit (loss); i.e. Orsafoam

Income from other associates: income from associates not considered as being part of the Group's core business are not integrated in Operating profit (loss); i.e. Proseat and Automotive Interiors

2. Earnings per share

in EUR 2019
restated1
2020 D
Number of shares outstanding (including treasury shares) 55 070 639 55 742 920 1.2%
Weighted average number of shares outstanding (before dilution effect) 54 959 861 55 174 425 0.4%
Weighted average number of shares outstanding (after dilution effect) 55 154 501 55 381 032 0.4%
Continuing operations
EBITDA 1.10 0.94 -15.3%
Operating profit (loss) 0.44 0.25 -43.5%
Result of the period before taxes 0.45 ( 0.03) n.m.
Earnings per share - continuing operations 0.44 ( 0.10) n.m.
Earnings per share - discontinued operations 0.01 1.24 n.m.
Earnings per share of continuing and discontinued operations 0.45 1.14 154.5%
Earnings per share from continuing operations
Basic 0.437 ( 0.100) n.m.
Diluted 0.436 ( 0.100) n.m.
Earnings per share from discontinued operations
Basic 0.012 1.245 9918.3%
Diluted 0.012 1.240 9916.3%
Net book value 5.00 6.01 20.1%

3. Condensed consolidated statement of comprehensive income

Group Recticel
in thousand EUR
2019 2020
Result for the period after taxes
Other comprehensive income
24 718 63 155
Items that will not subsequently be recycled to profit and loss
Actuarial gains (losses) on employee benefits recognized in equity ( 4 333) 420
Deferred taxes on actuarial gains (losses) on employee benefits 759 0
Currency translation differences ( 18) 161
Share in other comprehensive income in joint ventures & associates ( 655) ( 262)
Total ( 4 247) 319
Items that subsequently may be recycled to profit and loss
Hedging reserves 0 ( 70)
Currency translation differences
Foreign currency translation reserve difference recycled in the income
371
305
( 9 227)
18 311
statement
Deferred taxes on retained earnings
( 68) ( 113)
Share in other comprehensive income in joint ventures & associates
Total
158
766
( 2 098)
6 803
Other comprehensive income net of tax ( 3 481) 7 122
Total comprehensive income for the period 21 237 70 277
Total comprehensive income for the period 21 237 70 277
of which attributable to the owners of the parent
of which attributable to non-controlling interests
21 243
( 6)
70 273
4

4. Condensed consolidated statement of financial position

Group Recticel
in thousand EUR
31 Dec 2019
as published
31 Dec 2020
Intangible assets 14 306 14 806
Goodwill 24 412 24 139
Property, plant & equipment 227 617 173 000
Right-of-use assets 105 110 75 377
Investment property 3 331 3 331
Investments in associates 54 512 12 351
Investments in other associates 10 953 11 030
Non-current receivables 26 383 25 760
Other non-current contract assets 11 138 0
Deferred taxes 24 108 25 298
Non-currrent assets 501 869 365 092
Inventories 101 797 90 833
Trade receivables 99 117 102 726
Other current contract assets 11 300 0
Other receivables and other financial assets 32 667 57 929
Income tax receivables 1 448 1 452
Other investments 154 170
Cash and cash equivalents 48 479 79 255
Assets held for sale 5 638 1 300
Current assets 300 600 333 665
TOTAL ASSETS 802 469 698 757
Capital 138 494 139 357
Share premium 130 334 131 267
Share capital 268 828 270 624
Treasury shares ( 1 450) ( 1 450)
Other reserves ( 25 621) ( 22 487)
Retained earnings 51 227 98 760
Hedging and translation reserves ( 18 288) ( 11 372)
Equity (share of the Group) 274 696 334 075
Equity attributable to non-controlling interests 701 705
Total equity 275 397 334 780
Pensions and similar obligations 57 860 52 342
Provisions 6 905 18 979
Deferred taxes 10 023 12 173
Financial liabilities 100 334 70 426
Non-current contract liabilities 20 339 0
Other amounts payable 43 26
Non-current liabilities 195 504 153 946
Provisions 5 759 1 598
Financial liabilities 117 415 14 403
Trade payables 93 008 88 923
Current contract liabilities 32 832 15 183
Income tax payables 1 229 1 045
Other amounts payable 81 325 88 879
Current liabilities 331 568 210 031
TOTAL EQUITY AND LIABILITIES 802 469 698 757

5. Condensed consolidated statement of cash flow

Group Recticel
in thousand EUR
2019
restated
2020
Operating profit (loss) 24 417 13 848
Income from discontinued operations 683 68 692
Depreciation, amortisation and impairment losses on assets 58 070 49 673
Write-offs (-back) on assets and shares of affiliates 667 1 359
Changes in provisions -6 740 7 617
(Gain)/Loss on disposal of assets -3 740 - 132
(Gain)/Loss on disposal of shares 0 -101 674
Income from associates -1 294 - 704
Other non-cash elements 273 607
Gross operating cash flow 72 336 39 286
Changes in working capital and long-term receivables -1 668 -30 952
Gross operating cash flow after changes in working capital 70 668 8 334
Income taxes paid -3 899 -5 188
Net cash flow from operating activities (a) 66 768 3 146
Net cash flow from investment activities (b) -30 717 165 669
Paid interest charges on financial debt (c) -2 453 -2 147
Paid interest charges on lease debt - 146 - 125
Paid dividends -13 163 -13 254
Increase (Decrease) of capital 819 1 797
Increase of financial debt 51 169 97 523
Decrease of financial debt -13 151 -202 895
Reimbursement of lease liabilities (d) -24 466 -20 573
Net cash flow from financing activities (e) -1 391 -139 674
Effect of exchange rate changes (f) - 697 1 635
Changes in cash and cash equivalents (a)+(b)+(e)+(f) 33 963 30 776
FREE CASH FLOW (a)+(b)+(c)+(d) 8 987 145 970
Group Recticel
in thousand EUR
Capital Share premium Treasury shares Other reserves Retained
earnings
Translation
differences
reserves and
Hedging reserves
Total
shareholders'
equity
Non-controlling
interests
Total equity, non
controlling
interests included
At the end of the period
31 December 2019
138 494 130 334 -1 450 -25 621 51 227 -18 288 274 696 701 275 397
Dividends 0 0 0 0 -13 299 0 -13 299 0 -13 299
Stock options (IFRS 2) 0 0 0 609 0 0 609 0 609
Capital movements 863 933 0 0 0 0 1 796 0 1 796
Shareholders' movements 863 933 0 609 -13 299 0 -10 894 0 -10 894
Profit or loss of the period 0 0 0 0 63 151 0 63 151 4 63 155
Other comprehensive income' 0 0 0 319 - 107 -11 401 -11 189 0 -11 189
Change in scope 0 0 0 2 145 -2 145 18 311 18 311 0 18 311
Comprehensive income 0 0 0 2 464 -2 252 6 910 7 122 0 7 122
Reclassification 0 0 0 61 - 61 0 0 0 0
At the end of the period
31 December 2020
139 357 131 267 -1 450 -22 487 98 766 -11 378 334 075 705 334 780

6. Condensed consolidated statement of changes in shareholders' equity

7. Reconciliation with alternative performance measures

Group Recticel 31 DEC 2019 31 DEC 2020
in thousand EUR
Income statement
restated 1
Sales 878 521 828 793
Gross profit 168 664 154 474
EBITDA 60 715 51 609
Operating profit (loss) 24 417 13 848
Operating profit (loss) 24 417 13 848
Amortisation intangible assets
Depreciation tangible assets
1 942
33 018
1 933
32 377
Amortisation deferred charges long term 943 1 011
Impairments on goodwill, intangible and tangible fixed assets 395 2 439
EBITDA 60 715 51 609
EBITDA 60 715 51 609
Restructuring charges 6 654 2 034
Other 3 375 5 198
Adjusted EBITDA 70 744 58 841
Operating profit (loss) 24 417 13 848
Restructuring charges 6 654 2 034
Other
Impairments
3 375
395
5 198
2 439
Adjusted Operating profit (loss) 34 841 23 519
31 DEC 2019
Total net financial debt as published 31 DEC 2020
Non-current financial liabilities
Current financial liabilities
100 334
117 415
70 426
14 403
Cash ( 48 479) ( 79 255)
Other financial assets 1 ( 712) ( 999)
Net financial debt on statement of financial position 168 558 4 575
Factoring programs
Total net financial debt
47 051
215 609
0
4 575
1
Hedging instruments and interest advances
Gearing ratio (Net financial debt / Total equity)
Total equity 275 397 334 780
Net financial debt on statement of financial position / Total equity 61.2% 1.4%
Total net financial debt / Total equity 78.3% 1.4%
Leverage ratio (Net financial debt / EBITDA)
EBITDA (last 12 months) 60 715 51 609
Net financial debt on statement of financial position / EBITDA 2.8 0.1
Total net financial debt / EBITDA 3.6 0.1
Net working capital
Inventories and contracts in progress 101 797 90 833
Trade receivables
Current contract assets
99 117
11 300
102 726
0
Other receivables 32 667 57 929
Income tax receivables 1 449 1 452
Trade payables ( 93 008) ( 88 923)
Current contract liabilities
Income tax payables
( 32 832)
( 1 229)
( 15 183)
( 1 045)
Other amounts payable ( 81 325) ( 88 879)
Net working capital 37 936 58 910
Current ratio (= Current assets / Current liabilities)
Current assets
Current liabilities
300 600
332 264
333 665
210 031
Current ratio (factor) 0.9 1.6

8. Auditor's report

The statutory auditor, Deloitte Bedrijfsrevisoren CVBA, represented by Kurt Dehoorne, has confirmed that the audit, which is substantially complete, has not to date revealed any material misstatement in the draft consolidated income statement, consolidated statement of total comprehensive income, consolidated statement of financial position and consolidated statement of cash flows, and that the accounting data reported in the press release is consistent, in all material respects, with the draft consolidated income statement, consolidated statement of total comprehensive income, consolidated statement of financial position and consolidated statement of cash flows from which it has been derived.

Glossary

IFRS measures

Consolidated (data) : financial data follow ing the application of IFRS 11, w hereby joint ventures and associates are integrated on the basis of the equity method.

Alternative Performance Measures

In addition, the Group uses alternative performance measures (Alternative Performance Measures or "APM") to express its underlying performance and to help the reader to better understand the results. APM are not defined performance indicators by IFRS. The Group does not present APM as an alternative to financial measures determined in accordance w ith IFRS and does not give more emphasis to APM than the defined IFRS financial measures.

Adjusted EBITDA : EBITDA before Adjustments (to Operating Profit)

Adjusted operating profit (loss) : Operating profit (loss) + adjustments to operating profit (loss)

  • Adjustments to Operating profit (loss) : include operating revenues, expenses and provisions that pertain to restructuring programmes (redundancy payments, closure & clean-up costs, relocation costs,...), reorganisation charges and onerous contracts, impairments on assets ((in)tangible assets and goodw ill), revaluation gains or losses on investment property, gains or losses on divestments of nonoperational investment property, and on the liquidation of investments in affiliated companies, revenues or charges due to important (inter)national legal issues and costs of advisory fees incurred in relation to acquisitions or business combination projects.
  • Current ratio : Current assets / Current liabilities
  • EBITDA : Operating profit (loss) + depreciation, amortisation and impairment on assets; all of continued activities
  • Gearing : Net financial debt / Total equity
  • Income from associates : income from associates considered as being part of the Group's core business are integrated in Operating profit (loss); i.e. Orsafoam
  • Income from other associates : income from associates not considered as being part of the Group's core business are not integrated in Operating profit (loss); i.e. Proseat and Automotive Interiors
  • Leverage : Net financial debt / EBITDA (last 12 months)
  • Net free cash-flow : Net free cash flow : is the sum of the (i) Net cash flow after tax from operating activities, (ii) the Net cash flow from investing activities, (iii) the Interest paid on financial liabilities and (iv) reimbursement of lease liabilities; as show n in the consolidated cash flow statement.
  • Net financial debt : Interest bearing financial liabilities and lease liabilities at more than one year + interest bearing financial liabilities and lease liabilities w ithin maximum one year + accrued interests – cash and cash equivalents + Net marked-to-market value position of hedging derivative instruments. The interestbearing borrow ings do not include the draw n amounts under non-recourse factoring/forfeiting programs
  • Net w orking capital : Inventories and contracts in progress + Trade receivables + Other receivables + Income tax receivables – Trade payables – Income tax payables – Other amounts payable
  • Operating profit (loss) : Profit before income from other associates, fair value adjustments of option structures, earnings of discontinued activities, interests and taxes. Operating profit (loss) comprises income from associates of continued activities.
  • Total net financial debt : Net financial debt + the draw n amounts under off-balance sheet non-recourse factoring programs

Uncertainty risks concerning the forecasts made

This press report contains forecasts which entail risks and uncertainties, including with regard to statements concerning plans, objectives, expectations and/or intentions of the Recticel Group and its subsidiaries. Readers are informed that such forecasts entail known and unknown risks and/or may be subject to considerable business, macroeconomic and competition u ncertainties and unforeseen circumstances which largely lie outside the control of the Recticel Group. Should one or more of these risks, uncertainties or unforeseen or unexpected circumstances arise or if the underlying assumptions were to prove to be incorrect, the final financial results of the Group may possibly differ significantly from the assumed, expected, estimated or extrapolated results. Consequently, neither Recticel nor any other person assumes any responsibility for the accuracy of these forecasts.

Financial calendar

Annual results 2020 26.02.2021 (at 07:00 AM CET) First quarter 2021 trading update 27.04.2021 (at 07:00 AM CET) Annual General Meeting 25.05.2021 (at 10:00 AM CET) First half-year 2021 results 27.08.2021 (at 07:00 AM CET) Third quarter 2021 trading update 29.10.2021 (at 07:00 AM CET) Annual results 2021 25.02.2022 (at 07:00 AM CET)

For additional information

RECTICEL
avenue du Bourget/Bourgetlaan 42, 1130 Brussels
PRESS INVESTOR RELATIONS
Mr Olivier Chapelle Mr Michel De Smedt
Tel: +32 2 775 18 01 Mobile: +32 479 91 11 38
[email protected] [email protected]

Recticel in a nutshell

Recticel is a Belgian Group w ith a strong European dimension, but it also operates in the rest of the w orld. Recticel (excluding minority stakes in joint ventures) employs 4,221 people in 41 establishments in 20 countries.

Recticel contributes to daily comfort w ith high performance insulation solutions, mattresses and slat bases of top brands and an extensive range of polyurethane foam products for industrial and domestic applications.

Within Recticel's Insulation segment, the high-quality thermal insulation products are marketed under the w ellknow n brands Eurow all®, Pow erroof®, Pow erdeck®, Pow erw all® and Xentro®. Recticel is also the Group behind the bedding brands (Beka®, Lattoflex®, Literie Bultex®, Schlaraffia®, Sembella®, Sw issflex®, Superba®, etc.) and GELTEX®.

In 2020 Recticel achieved consolidated sales of EUR 828.8 million.

Recticel (Euronext: REC – Reuters: RECTt.BR – Bloomberg: REC:BB) is listed on Euronext in Brussels.

The press release is available in English and Dutch on the website www.recticel.com

Talk to a Data Expert

Have a question? We'll get back to you promptly.